US OptionsDetailed Quotes
RIGL250117P18000
- 1.76
- 0.000.00%
15min DelayClose Jan 3 16:00 ET
0.00High0.00Low
1.76Open1.76Pre Close0 Volume1 Open Interest18.00Strike Price0.00Turnover110.17%IV6.56%PremiumJan 17, 2025Expiry Date0.62Intrinsic Value100Multiplier12DDays to Expiry1.14Extrinsic Value100Contract SizeAmericanOptions Type-0.5247Delta0.1119Gamma9.88Leverage Ratio-0.0561Theta-0.0034Rho-5.18Eff Leverage0.0129Vega
Rigel Pharmaceuticals Stock Discussion
whoa! some Dip
Rigel Announces R289 Granted Fast Track Designation by the FDA for Lower-Risk MDS
Rigel Pharmaceuticals (Nasdaq: RIGL) announced that the FDA has granted Fast Track designation to R289 for treating patients with previously-treated transfusion dependent lower-risk myelodysplastic syndrome (LR-MDS). R289, a dual inhibitor of IRAK1 and IRAK4, is currently being evaluated in a Phase 1b study. The Fast Track designation may provide benefits including more freque...
Rigel Announces R289 Granted Fast Track Designation by the FDA for Lower-Risk Mds
Let's break 30.+
27.+
No comment yet